TrialBrain communications2024

The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma.

Jorien B E Janssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.